TheNote
GSK announces positive results... Note
GooglePlay AppStore
GSK press releases

GSK announces positive results from B-Well 1 and B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B

Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate
https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-b-well-1-and-b-well-2-phase-iii-trials-for-bepirovirsen-a-potential-first-in-class-treatment-for-chronic-hepatitis-b/ gsk.com
RSS Hunter RSS Hunter • Jan 7

Cookies help us deliver our Services. By using our Services or clicking I agree, you agree to our use of cookies .